For the quarter ending 2026-01-31.
| Income Statement | 2026-01-31 | 2025-10-31 | 2025-07-31 | |
|---|---|---|---|---|
| Revenue | 0 | 2,419 | 1,900 | |
| Cost of sales | 0 | 1,008 | 760 | |
| Gross margin | 0 | 1,411 | 1,140 | |
| Research and development | 638,575 | 727,026 | 997,206 | |
| Selling, general and administrative | 1,290,365 | 1,347,788 | 878,053 | |
| Total operating expenses | 1,928,940 | 2,074,814 | 1,875,259 | |
| Loss from operations | -1,928,940 | -2,073,403 | -1,874,119 | |
| Interest expense | 61,509 | 279,534 | 183,688 | |
| Other income | 5,241 | 2,168 | 2,813 | |
| Total other expense | -56,268 | -277,366 | -180,875 | |
| Net loss | -1,985,208 | -2,350,769 | -2,054,994 | |
| Basic EPS | -0.63 | -0.85 | -1.58 | |
| Diluted EPS | - | -0.85 | -1.58 | |
| Basic Average Shares | 3,162,257 | 2,780,496 | 1,303,532 | |
| Diluted Average Shares | - | 2,780,496 | 1,303,532 | |
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)